Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bioxodes

Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101
From Bioxodes
Via GlobeNewswire
Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients
From Bioxodes
Via GlobeNewswire
Bioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe
From Bioxodes
Via GlobeNewswire
Bioxodes secures new funds to reach early 2025 milestones and pursue Series B financing
From Bioxodes
Via GlobeNewswire
Bioxodes meets enrollment milestone in Phase 2a intracerebral hemorrhagic stroke trial
From Bioxodes
Via GlobeNewswire
Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke
From Bioxodes
Via GlobeNewswire
Bioxodes meets first Phase 2a patient enrollment milestone with BIOX-101 in intracerebral hemorrhagic stroke
From Bioxodes
Via GlobeNewswire
Bioxodes receives European Patent Office intention to grant patent, offering lead asset broad protection in thromboinflammation
From Bioxodes
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.